Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans

Journal of Immunology

Volumn 162, Issue 5, 1999, Pages 3088-3095

  Livingston, Brian D ^a   Alexander, Jeff ^a   Crimi, Claire ^a   Oseroff, Carla ^a   Celis, Esteban ^a   Daly, Kieran ^a   Guidotti, Luca G ^b   Chisari, Francis V ^b   Fikes, John ^a   Chesnut, Robert W ^a   Sette, Alessandro ^a  

^a Epimmune   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITOPE; GAMMA INTERFERON; HEPATITIS B VACCINE; HLA A2 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 2; MITOGENIC AGENT; TETANUS TOXOID; VIRUS VACCINE;

ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; VACCINATION;

ANIMALS; CYTOKINES; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HLA-A2 ANTIGEN; HUMANS; IMMUNE TOLERANCE; LIPOPROTEINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; VACCINATION;

EID: 0033104746     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Penna, A., F. V. Chisari, A. Bertoletti, G. Missale, P. Fowler, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1991. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. 174:1565.
2. Nayersina, R., P. Fowler, S. Guilhot, G. Missale, A. Cerny, H. J. Schlicht, A. Vitiello, R. Chesnut, J. L. Person, A. G. Redeker, and F. V. Chisari. 1993. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150:4659.
3. Missale, G., A. Redeker, J. Person, P. Fowler, S. Guilhot, H. J. Schlicht, C. Ferrari, and F. V. Chisari. 1993. HLA-A31 and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med. 177:751.
4. Guidotti, L. G., K. Ando, M. V. Hobbs, T. Ishikawa, L. Runkel, R. D. Schreiber, and F. V. Chisari. 1994. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA 91:3764.
5. Guidotti, L. G., S. Guilhot, and F. V. Chisari. 1994. Interleukin-2 and interferon α/β downregulate hepatitis B virus gene expression in vivo by tumor necrosis factor dependent and independent pathways. J. Virol. 68:1265.
6. Guidotti, L. G., B. Matzke, H. Schaller, and F. V. Chisari. 1995. High level hepatitis B virus replication in transgenic mice. J. Virol. 69:6158.
7. Gilles, P. N., G. Fey, and F. V. Chisari. 1992. Tumor necrosis factor α negatively regulates hepatitis B virus gene expression in transgenic mice. J. Virol. 66:3955.
8. Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29.
9. Rock, K. L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 17:131.
10. Franco, A., L. G. Guidotti, M. V. Hobbs, V. Pasquetto, and F. V. Chisari. 1997. Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice. J. Immunol. 159:2001.
11. Vitiello, A., G. Ishioka, H. M. Grey, R. Rose, P. Farness, R. LaFond, L. Yuan, F. V. Chisari, J. Furze, R. Bartholomeuz, and R. W. Chesnut. 1995. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. J. Clin. Invest. 95:341.
12. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929.
13. delGuercio, M.-F., J. Sidney, G. Hermanson, C. Perez, H. M. Grey, R. T. Kubo, and A. Sette. 1994. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 154:685.
14. Wentworth, P. A., E. Celis, C. Crimi, S. Stitley, L. Hale, V. Tsai, H. M. Serra, M.-F. delGuercio, B. Livingston, D. Alazard, J. Fikes, R. Kubo, H. M. Grey, R. W. Chesnut, F. V. Chisari, and A. Sette. 1995. In vitro induction of primary antigen specific CTL from human PBMC stimulated with synthetic peptides. Mol. Immunol. 32:603.
15. Panina-Bordignon, P., A. Tan, A. Termijtelen, S. Demotz, G. Corradin, and A. Lanzavecchia 1989. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 19:2237.
16. Livingston, B. D., C. Crimi, H. Grey, G. Ishioka, F. V. Chisari, J. Fikes, H. Grey, R. W. Chesnut, and A. Sette. 1997. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection. J. Immunol. 159:1383.
17. Atherton, E., and R. C Sheppard. 1989. Fluorenylmethoxycarbnyl-polyamide solid phase peptide synthesis-general principles and development. In Solid Phase Peptide Synthesis: A Practical Approach. IRL Press at Oxford University Press, Oxford, pp. 25-37.
18. Alexander, J. J. Sidney, S. Southwood, J. Ruppert, C. Oseroff, A. Maewal, K. Snoke, H. M. Serra, R. T. Kubo, A. Sette, and H. M. Grey. 1994. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity 1:751.
19. Uyttenhove, C., J. Van Snick, and T. Boon. 1980. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815 I Rejection by syngeneic mice J. Exp. Med. 152:1175.
20. Ando, K., L. G. Guidotti, S. Wirth, T. Ishikawa, G. Missale, T. Moriyama, R. D. Schreiber, H. Schlicht, S. Huang, and F. V. Chisari. 1994. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152:3245.
21. Bertoletti, A., M. M. D'Elios, C. Boni, M. De Carli, A. L. Zignego, M. Durazzo, G. Missale, A. Penna, F. Fiaccadori, G. Del Prete, and C. Ferrari. 1997. Different cytokine patterns of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 112:193.
22. Penna, A., G. Del Prete, A. Cavalli, A. Bertoletti, M. M. D'Elios, R. Sorrentino, M. D'Amato, C. Boni, M. Pilli, F. Fiaccadori, and C. Ferrari. 1997. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 25:1022.
23. Milich, D. R., S. F. Wolf, J. L. Hughes, and J. E. Jones. 1995. Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice. Proc. Natl. Acad. Sci. USA 92:6847.
24. Maruyama, T., A. McLachlan, S. Iion, K. Koike, K. Kurokawa, and D. R. Milich. 1993. The Serology of chronic hepatitis B infection revisited. J. Clin. Invest. 91:2586.
25. DeWit, D., M. VanMechelen, M. Ryeland, A. C. Figueiredo, D. Abramowicz, M. Goldman, H. Bazin, J. Urbain, and O. Leo. 1992. The injection of deaggregrated γ globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes. J. Exp. Med. 175:9.
26. Burstein, H., C. A. Shea, and A. K. Abbas. 1992. Aqeous antigens induce in vivo tolerance selectively in IL-2 and IFN-γ producing (Th1) cells. J. Immunol. 148: 3687.
27. De Smedt T., M. Van Mechelen, G. De Becker, J. Urbain, O. Leo, and M. Moser. 1997. Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27:1229.
28. Steinbrink, K, M. Wolfl, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772.
29. Kalinski, P., C. M. Hilkens, A. Snijders., F. G. Snijdewint, and M. L. Kapsenberg. 1997. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159:28.
30. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737.
31. Kurose, K., S. M. Akbar, K. Yamamoto, and M. Onji. 1997. Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells. Immunology 92:494.
32. Rossol, S., G. Marinos, P. Carucci, M.V. Singer, R. Williams, and N. V. Naoumov. 1997. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J. Clin. Invest. 99:3025.
33. Collier, J., and J. Heathcote. 1998. Hepatitis C viral infection in the immuno-suppressed patient. Hepatology 27:2.
34. McCaughan, G. W., J. Napoli, P. McGuinness, and G. A. Bishop. 1997. T1 vs T2 cytokine responses in chronic HCV: implications for mechanisms of liver injury. Viral Hepatitis 3:129.
35. Fu, E. J., M. J. Arca, J. M. Hain, R. Krinock, J. Rado, M. J. Cameron, A. E. Chang, and V. K. Sondak 1997. Tumor-induced suppression of antitumor reactivity and depression of TCR zeta expression in tumor-draining lymph node lymphocytes: possible relationship to the Th2 pathway. J. Immunother. 20:111.
36. Wagstaff, A. J, D. Faulds, and K. L. Goa. 1994. Acyclovir: a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 47: 153.
37. Dienstag, J. L., R. P. Perillo, E. R. Schiff, M. Bartholomew, C. Vieary, and M. Robin. 1995. A preliminary trial of Lamivudine for chronic hepatitis B infection. N. Engl. J. Med. 333:1657.
38. Boni, C., A. Bertoletti, A. Penna, A. Cavalli, M. Pilli, S. Urbani, P. Scognamiglio, R. Boehme, R. Panebianco, F. Fiaccadori, and C. Ferrari. 1998. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J. Clin. Invest. 102:968.